image credit: Unsplash

BioNTech to start building mRNA vaccine manufacturing plant in Africa in mid-2022

October 26, 2021

BioNTech will construct a facility to make its mRNA vaccines in Africa in mid-2022 to scale up production of its COVID-19 jab for a continent that has been largely left behind in the global rollout of vaccines. Planning for the facility has been finalized and “initial assets” have been ordered, the German biotech said Tuesday.

That timing sets the Pfizer partner up to potentially beat out Moderna in building the first mRNA vaccine manufacturing site on the continent.

Read More on FiercePharma